Filippo Scialò

1.1k total citations
36 papers, 753 citations indexed

About

Filippo Scialò is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Filippo Scialò has authored 36 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Filippo Scialò's work include COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Filippo Scialò is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Filippo Scialò collaborates with scholars based in Italy, United Kingdom and Iraq. Filippo Scialò's co-authors include Giuseppe Castaldo, Andrea Bianco, Aurora Daniele, Felice Amato, Lucio Pastore, Mario Cazzola, Maria Gabriella Matera, Monica Gelzo, Mario Siervo and Gustavo Cernera and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Filippo Scialò

33 papers receiving 744 citations

Peers

Filippo Scialò
Filippo Scialò
Citations per year, relative to Filippo Scialò Filippo Scialò (= 1×) peers Zhaolong Cao

Countries citing papers authored by Filippo Scialò

Since Specialization
Citations

This map shows the geographic impact of Filippo Scialò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Scialò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Scialò more than expected).

Fields of papers citing papers by Filippo Scialò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Scialò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Scialò. The network helps show where Filippo Scialò may publish in the future.

Co-authorship network of co-authors of Filippo Scialò

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Scialò. A scholar is included among the top collaborators of Filippo Scialò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Scialò. Filippo Scialò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viscardi, Giuseppe, Lucio Pastore, Giuseppe Castaldo, et al.. (2025). Unraveling Resistance in Lung Cancer Immunotherapy: Clinical Milestones, Mechanistic Insights, and Future Strategies. International Journal of Molecular Sciences. 26(18). 9244–9244.
2.
Villella, Valeria Rachela, et al.. (2025). How Effectively Can Oxidative Stress and Inflammation Be Reversed When CFTR Function Is Pharmacologically Improved?. Antioxidants. 14(3). 310–310. 1 indexed citations
3.
Perrotta, Fabio, et al.. (2024). Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis. Respiratory Research. 25(1). 189–189. 4 indexed citations
4.
D’Agnano, Vito, Filippo Scialò, Giulia Maria Stella, et al.. (2024). Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders. Drugs. 84(5). 491–501. 5 indexed citations
5.
Esposito, Speranza, Valeria Rachela Villella, Filippo Scialò, et al.. (2024). Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation. Clinica Chimica Acta. 558. 118317–118317. 1 indexed citations
6.
Scialò, Filippo, Vito D’Agnano, Fabio Perrotta, et al.. (2023). Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders. Lung. 201(5). 455–466. 4 indexed citations
7.
Cioffi, Iolanda, Olivia Di Vincenzo, Nicola Imperatore, et al.. (2023). Amino acid profiles, disease activity, and protein intake in adult patients with Crohn’s disease. Frontiers in Nutrition. 10. 1245574–1245574. 7 indexed citations
8.
Cioffi, Iolanda, Filippo Scialò, Olivia Di Vincenzo, et al.. (2023). Serum Interleukin 6, Controlling Nutritional Status (CONUT) Score and Phase Angle in Patients with Crohn’s Disease. Nutrients. 15(8). 1953–1953. 8 indexed citations
9.
Perrotta, Fabio, Filippo Scialò, Giuseppe Signoriello, et al.. (2023). Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2. International Journal of Molecular Sciences. 24(2). 1131–1131. 22 indexed citations
10.
Scalia, Giulia, Maddalena Raia, Monica Gelzo, et al.. (2022). Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection. Journal of Clinical Medicine. 11(15). 4306–4306. 7 indexed citations
11.
Gelzo, Monica, Filippo Scialò, Sara Cacciapuoti, et al.. (2022). Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?. Viruses. 14(3). 534–534. 12 indexed citations
12.
Scialò, Filippo, Margherita Passariello, Eleonora Leggiero, et al.. (2022). Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model. Frontiers in Oncology. 12. 902190–902190. 13 indexed citations
13.
Gelzo, Monica, Sara Cacciapuoti, Biagio Pinchera, et al.. (2022). Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Scientific Reports. 12(1). 1212–1212. 67 indexed citations
14.
D’Agnano, Vito, Filippo Scialò, Francesco Perna, et al.. (2022). Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients. Life. 12(8). 1141–1141. 11 indexed citations
15.
Gelzo, Monica, Marco Maglione, Carolina D’Anna, et al.. (2022). Biomarkers of Endothelial Damage in Distinct Phases of Multisystem Inflammatory Syndrome in Children. Metabolites. 12(8). 680–680. 9 indexed citations
16.
17.
Gelzo, Monica, Sara Cacciapuoti, Biagio Pinchera, et al.. (2021). Further Findings Concerning Endothelial Damage in COVID-19 Patients. Biomolecules. 11(9). 1368–1368. 9 indexed citations
18.
Gelzo, Monica, Sara Cacciapuoti, Biagio Pinchera, et al.. (2021). Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?. Frontiers in Public Health. 9. 664108–664108. 21 indexed citations
19.
Bianco, Andrea, Tullio Valente, Fabio Perrotta, et al.. (2021). Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy. Heliyon. 7(5). e07112–e07112. 5 indexed citations
20.
Ashor, Ammar W., Oliver M. Shannon, Anke Werner, et al.. (2019). Effects of inorganic nitrate and vitamin C co-supplementation on blood pressure and vascular function in younger and older healthy adults: A randomised double-blind crossover trial. Clinical Nutrition. 39(3). 708–717. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026